Home › Drug Use and Addiction › NCT07104396

Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* At least 18 years
* PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.
* Training or trained in substance use disorder (SUDs) research.
* Must state a specific interest in digital therapeutics for SUDs.

Exclusion Criteria:

* Those who do not meet inclusion criteria.

About the study

This is a research study to evaluate the usability of the Cogito digital therapeutics development platform.

The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population.

And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).

What is being tested

• Cogito digital therapeutics development platform (other)

Sponsor: Square2 Systems, Inc. · Participants: 20 · Started: Jul 2, 2025

Contact the study team

• Square2 Systems · Phone: (802) 526-4608

Official record on ClinicalTrials.gov — NCT07104396

Locations in the U.S.

Conditions

• Drug Use and Addiction

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.